USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/23969
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVinogradov, Igori-
dc.contributor.authorPerekhrestenko, Tetiana-
dc.contributor.authorKarnabeda, Oksana-
dc.contributor.authorSatcovscaia, Inna-
dc.contributor.authorBuruiana, Sanda-
dc.date.accessioned2023-03-27T11:49:48Z-
dc.date.available2023-03-27T11:49:48Z-
dc.date.issued2023-
dc.identifier.citationVINOGRADOV, Igori, PEREKHRESTENKO, Tetiana, KARNABEDA, Oksana, et al. Unmet needs in the treatment of chronic lymphocytic leukemia and prospects for patients in the Republic of Moldova. In: The Moldovan Medical Journal. 2023, vol. 66, no 1, pp. 77-82. ISSN 2537-6381. https://doi.org/10.52418/moldovan-med-j.66-1.23.12en_US
dc.identifier.issn2537-6373-
dc.identifier.issn2537-6381-
dc.identifier.urihttps://doi.org/10.52418/moldovan-med-j.66-1.23.12-
dc.identifier.urihttps://moldmedjournal.md/wp-content/uploads/2023/03/Moldovan-Med-J-2023-Vol.-66-No1.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/23969-
dc.description.abstractBackground: Chronic lymphocytic leukemia (CLL) is a malignant lymphoproliferative, monoclonal, indolent hemopathy characterized by pathologically increased synthesis of mature but immunologically dysfunctional B lymphocytes. CLL is considered the pathology of the adult with comorbidities, whose average age is 55 years, who is integrated into the work field. Despite advances in the field of medicine, CLL remains an incurable disease, but the use of targeted, personalized therapy with new agents’ conditions not only increases the life span, but also improves the of quality life of these patients, ensuring social, family and professional integration. This fact presents a favourable socioeconomic impact, a valuable indicator especially in countries with a low and medium socio-demographic index. The identification of biomarkers and the advent of personalized therapies have transformed the way the disease is treated and changed the lives and quality of life of CLL patients. Conclusions: CLL remains a current medical and socioeconomic problem, and the behaviour of patients with CLL remains a challenge for the health system in the Republic of Moldova. The implementation of cyto-genetic and molecular-biological diagnosis is important for the stratification of patients, the selection of optimal targeted therapy. CLL comorbidity is an independent indicator of treatment response, predisposes to adverse drug effects and reduces the quality of life of CLL patients. The individual approach to the patient with CLL, the administration of therapy according to international guidelines will give patients better chances of survival and a longer plateau of stabilization.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectchronic lymphocytic leukemiaen_US
dc.subjectpersonalized therapyen_US
dc.subject.ddcUDC: 616.155.392.2-036.12-08(478)en_US
dc.titleUnmet needs in the treatment of chronic lymphocytic leukemia and prospects for patients in the Republic of Moldovaen_US
dc.typeArticleen_US
Appears in Collections:Moldovan Medical Journal, March 2023, Vol. 66, No1

Files in This Item:
File Description SizeFormat 
Unmet_needs_in_the_treatment_of_chronic_lymphocytic_leukemia.pdf225.27 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback